滋阴凉血汤对慢性肾小球肾炎患者炎症因子及尿足细胞水平的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

上海市卫健委中医临床专项课题(20184Y0207);上海市中医医院第二批传承项目;上海市中医医院育苗计划


Effect of Ziyin Liangxue Decoction on inflammatory factors and urine podocyte in patients with chronic glomerulonephritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    探讨滋阴凉血汤对气阴两虚血瘀证慢性肾炎患者的炎症因子以及相关尿足细胞标记蛋白的干预作用。方法 选取2019年1月~2021年9月在上海市中医医院肾内科确诊为慢性肾小球肾炎的患者53例为研究对象,将患者随机分为治疗组(28例)和对照组(25例)。所有患者均给予基础治疗,对照组在此基础上给予厄贝沙坦片150 mg口服,治疗组在对照组基础上给予滋阴凉血汤剂。观察两组治疗前后的中医证候积分及24 h尿蛋白定量(24 h UPro)、尿白蛋白/尿肌酐、肾功能、肿瘤坏死因子-α(TNF-α)、糖萼蛋白(PCX)、肾病蛋白(Nephrin)、肾小球足细胞裂隙膜蛋白(Podocin)。〖HTH〗结果 两组患者治疗前后24 h-UPro、尿白蛋白/尿肌酐组内比较,差异均有统计学意义(P<0.05);两组治疗前后24 h-UPro、尿白蛋白/尿肌酐组间比较差异无统计学意义(均P>0.05)。两组患者治疗前后TNF-α组内、组间比较,差异均有统计学意义(P<0.05)。治疗组尿PCX治疗前后比较,差异有统计学意义(P<0.01),对照组尿PCX治疗前后组间比较,差异无统计学意义(P=0.188);治疗组与对照组尿PCX治疗前后组间比较,差异均有统计学意义(P<0.01)。两组患者尿Nephrin、尿Podocin治疗前后组内、组间比较,差异均有统计学意义(P<0.05)。两组患者治疗前后中医症候积分组内及组间比较,差异均有统计学意义(P<0.01)。临床观察过程中,治疗组和对照组均未发生不良反应事件。结论 与对照组相比,服用滋阴凉血汤的治疗组能更好的减轻慢性肾炎患者的相关症状,改善患者的免疫炎症损伤及肾小球足细胞损伤,从而达到降低蛋白尿、延缓疾病进展的目的

    Abstract:

    To observe the intervention effect of Ziyin Liangxue Decoction on inflammatory factors and related podocyte marker proteins in chronic nephritis patients with Qi-yin deficiency and blood stasis syndrome, laying a good foundation for further study of its therapeutic mechanism and pathway.Methods Fifty-three patients diagnosed with chronic glomerulonephritis in the Department of Nephrology, Shanghai Hospital of Traditional Chinese Medicine from January 2019 to September 2021 were selected as the study objects, and the patients were randomly divided into a treatment group (28 cases) and a control group (25 cases). All patients were given basic treatment, control group was additionally given irbesartan tablets 150 mg orally, and treatment group was additionally given nourishing Yin and cooling blood decoction. The TCM syndrome integral and 24 h urine protein quantitative UPro (24 h), urinary albumin/uric creatinine and kidney function, tumor necrosis factor-alpha (TNF-alpha) protein, sugar, calyx (PCX) protein (Nephrin), kidney disease, glomerular podocyte fissure membrane protein (Podocin) were observed.Results 24 h-UPro, urine albumin/uric creatinine of the two groups before treatment were significantly different from that of 24 h-UPro, urine albumin/uric creatinine of the two groups after treatment (P<0.05). 24 h-UPro, urine albumin/uric creatinine before and after treatment of treatment group were not significantly different from that of control group (P>0.05). TNF-α before and after treatment of the two groups were significantly different (P<0.05). PCX of treatment group after treatment was different from that of before treatment (P<0.05). PCX of control group after treatment was not different from that of before treatment (P>0.05). PCX after treatment of treatment group was different from that of control group (P<0.05). Urinary Nephrin and Podocin of the two group before and after treatment were significantly different (P<0.05). TCM symptom integral of the two group before and after treatment were significantly different (P<0.05). In the course of clinical observation, no adverse events occurred in the treatment group and the control group. Conclusion Compared with the control group, the treatment group taking Ziyin Liangxue Decoction can relieve the related symptoms of chronic nephritis patients, improve the immune inflammation damage and glomerular podocyte damage, and reduce proteinuria and delay disease progression

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-17
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司